Article(id=1329869445671007169, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869401546928487, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.01.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1669564800000, receivedDateStr=2022-11-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794995183626, onlineDateStr=2026-11-18, pubDate=1673280000000, pubDateStr=2023-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794995183626, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794995183626, creator=13701087609, updateTime=1794995183626, updator=13701087609, issue=Issue{id=1329869401546928487, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='1', pageStart='1', pageEnd='100', issueExtLink='null', onlineDate='null', pubDate='1673280000000', pubDateStr='2023-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794995173107, creator='13701087609', updateTime=1794995764620, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329871882981060993, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869401546928487, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329871882981060994, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329869401546928487, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=8, endPage=14, ext={EN=ArticleExt(id=1329869445880722370, articleId=1329869445671007169, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress on endothelin receptor antagonist in the treatment of diabetic nephropathy, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Diabetic nephropathy (DN) is a chronic microvascular complication of diabetes mellitus (DM), which is also the main cause of end-stage renal disease (ESRD). The prevalence rate of DM related chronic kidney disease (CKD) has exceeded that of glomerulonephritis (GN) related CKD. DN has become a big social problem for Chinese residents. The main treatment options for DN are lifestyle change and drug therapy, but currently common drugs can only reduce symptoms and delay disease progression, and new drugs are needed to improve the overall outcome of DN patients. Endothelin receptor antagonist (ERA), a new class of drugs used in DN in recent years, has shown good effects. This article summarized the clinical research progress of ERA in the treatment of DN, aiming to provide reference for clinical practice.

, authors=Sijie GU, Ying FAN, Niansong WANG*, authorsList=Sijie GU, Ying FAN, Niansong WANG, authorCompany=null, correspAuthors=Niansong WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329869446119797699, articleId=1329869445671007169, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=内皮素受体拮抗剂治疗糖尿病肾病研究进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

糖尿病肾病(diabetic nephropathy,DN)是糖尿病(diabetes mellitus,DM)慢性微血管并发症之一,也是导致终末期肾病(end-stage renal disease,ESRD)的主要原因。我国DM相关慢性肾脏病(chronic kidney disease,CKD)患病率已超过肾小球肾炎(glomerulonephritis,GN)相关CKD,DN已成为危害我国居民健康的一大社会问题。DN治疗方案主要为生活方式改变和药物治疗,但目前临床常用药物仅能减轻症状,延缓疾病进展,需新型药物以改善DN患者总体结局。内皮素受体拮抗剂(endothelin receptor antagonist,ERA)是一类近年被应用于DN治疗的新型药物,效果良好。现对ERA在DN治疗中的临床研究进展作一综述,旨在为临床提供参考。

, authors=顾思捷, 范瑛, 汪年松*, authorsList=顾思捷, 范瑛, 汪年松, authorCompany=null, correspAuthors=汪年松, authorNote=

顾思捷,主治医师,博士研究生在读,研究方向:中西医结合。

, correspAuthorsNote=
汪年松,主任医师,教授,博士研究生导师,研究方向:糖尿病肾脏疾病、急性肾损伤的发病机制和防治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=asTJULqxKz80R8emBJMi6g==, magXml=wtX3wZB8fLoR3mHlq+TZ+g==, pdfUrl=null, pdf=XYh/O9yhsK+Fdl35oGs8lw==, pdfFileSize=1539820, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=OIzCIxeGO3J+J9/3jo6Lcg==, mapNumber=null, fund=null)}, authors=[Author(id=1329869446388233160, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869446455342026, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446388233160, language=EN, stringName=Sijie GU, firstName=Sijie, middleName=null, lastName=GU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869446514062283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446388233160, language=CN, stringName=顾思捷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio={"content":"

顾思捷,主治医师,博士研究生在读,研究方向:中西医结合。

"}, bioImg=null, bioContent=

顾思捷,主治医师,博士研究生在读,研究方向:中西医结合。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869446300152772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, xref=null, ext=[AuthorCompanyExt(id=1329869446308541381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869446316929990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])]), Author(id=1329869446581171149, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869446644085711, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446581171149, language=EN, stringName=Ying FAN, firstName=Ying, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869446711194576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446581171149, language=CN, stringName=范瑛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869446300152772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, xref=null, ext=[AuthorCompanyExt(id=1329869446308541381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869446316929990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])]), Author(id=1329869446765720530, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329869446845412308, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446765720530, language=EN, stringName=Niansong WANG, firstName=Niansong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869446904132565, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446765720530, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869446300152772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, xref=null, ext=[AuthorCompanyExt(id=1329869446308541381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869446316929990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])])], keywords=[Keyword(id=1329869446988018646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, language=EN, orderNo=1, keyword=endothelin receptor antagonist), Keyword(id=1329869447063516119, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, language=EN, orderNo=2, keyword=diabetic nephropathy), Keyword(id=1329869447122236376, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, language=EN, orderNo=3, keyword=chronic microvascular complication), Keyword(id=1329869447180956633, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, language=CN, orderNo=1, keyword=内皮素受体拮抗剂), Keyword(id=1329869447239676890, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, language=CN, orderNo=2, keyword=糖尿病肾病), Keyword(id=1329869447298397147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, language=CN, orderNo=3, keyword=慢性微血管并发症)], refs=[Reference(id=1329869447382283228, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Rubanyi GM. The discovery of endothelin: the power of bioassay and the role of serendipity in the discovery of endothelium-derived vasocative substances[J]. Pharmacol Res, 2011, 63(6): 448-454., articleTitle=null, refAbstract=null), Reference(id=1329869447445197789, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Hickey KA, Rubanyi G, Paul RJ, et al. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells[J]. Am J Physiol, 1985, 248(5 Pt 1): C550-C556., articleTitle=null, refAbstract=null), Reference(id=1329869447512306654, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Dhaun N, Webb DJ. Endothelins in cardiovascular biology and therapeutics[J]. Nat Rev Cardiol, 2019, 16(8): 491-502., articleTitle=null, refAbstract=null), Reference(id=1329869447575221215, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Anguiano L, Riera M, Pascual J, et al. Endothelin blockade in diabetic kidney disease[J]. J Clin Med, 2015, 4(6): 1171-1192., articleTitle=null, refAbstract=null), Reference(id=1329869447646524384, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Yamamoto T, Suzuki H, Kubo Y, et al. Endothelin A receptor-like immunoreactivity on the basal infoldings of rat renal tubules and collecting ducts[J]. Arch Histol Cytol, 2008, 71(2): 77-87., articleTitle=null, refAbstract=null), Reference(id=1329869447709438945, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Takemoto F, Uchida S, Ogata E, et al. Endothelin-1 and endothelin-3 binding to rat nephrons[J]. Am J Physiol, 1993, 264(5 Pt 2): F827-F832., articleTitle=null, refAbstract=null), Reference(id=1329869447772353506, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Terada Y, Tomita K, Nonoguchi H, et al. Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay[J]. J Clin Invest, 1992, 90(1): 107-112., articleTitle=null, refAbstract=null), Reference(id=1329869447835268067, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Bäcker A, Bokemeyer D, Kramer HJ. Endothelin synthesis and receptors in porcine kidney[J]. Acta Physiol Scand, 2001, 171(1): 105-112., articleTitle=null, refAbstract=null), Reference(id=1329869447889794020, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Guan Z, Vanbeusecum JP, Inscho EW. Endothelin and the renal microcirculation[J]. Semin Nephrol, 2015, 35(2): 145-155., articleTitle=null, refAbstract=null), Reference(id=1329869447956902885, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Inscho EW, Imig JD, Cook AK, et al. ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin[J]. Br J Pharmacol, 2005, 146(7): 1019-1026., articleTitle=null, refAbstract=null), Reference(id=1329869448024011750, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Schildroth J, Rettig-Zimmermann J, Kalk P, et al. Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice[J]. Nephrol Dial Transplant, 2011, 26(3): 779-789., articleTitle=null, refAbstract=null), Reference(id=1329869448086926311, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang S, Huang Q, Wang Q, et al. Enhanced renal afferent arteriolar reactive oxygen species and contractility to endothelin-1 are associated with canonical Wnt signaling in diabetic mice[J]. Kidney Blood Press Res, 2018, 43(3): 860-871., articleTitle=null, refAbstract=null), Reference(id=1329869448162423784, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Barton M, Shaw S, D'uscio LV, et al. Angiotensin Ⅱ increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation[J]. Biochem Biophys Res Commun, 1997, 238(3): 861-865., articleTitle=null, refAbstract=null), Reference(id=1329869448254698473, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Spires D, Poudel B, Shields CA, et al. Prevention of the progression of renal injury in diabetic rodent models with preexisting renal disease with chronic endothelin A receptor blockade[J]. Am J Physiol Renal Physiol, 2018, 315(4): F977-F985., articleTitle=null, refAbstract=null), Reference(id=1329869448330195946, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Yamauchi T, Ohnaka K, Takayanagi R, et al. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells[J]. FEBS Lett, 1990, 267(1): 16-18., articleTitle=null, refAbstract=null), Reference(id=1329869448401499115, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Barton M, Sorokin A. Endothelin and the glomerulus in chronic kidney disease[J]. Semin Nephrol, 2015, 35(2): 156-167., articleTitle=null, refAbstract=null), Reference(id=1329869448456025068, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Saleh MA, Boesen EI, Pollock JS, et al. Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes[J]. Diabetologia, 2011, 54(4): 979-988., articleTitle=null, refAbstract=null), Reference(id=1329869448523133933, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Morigi M, Buelli S, Angioletti S, et al. In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies[J]. Am J Pathol, 2005, 166(5): 1309-1320., articleTitle=null, refAbstract=null), Reference(id=1329869448594437102, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Lenoir O, Milon M, Virsolvy A, et al. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis[J]. J Am Soc Nephrol, 2014, 25(5): 1050-1062., articleTitle=null, refAbstract=null), Reference(id=1329869448653157360, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Garsen M, Lenoir O, Rops AL, et al. Endothelin-1 induces proteinuria by heparanase-mediated disruption of the glomerular glycocalyx[J]. J Am Soc Nephrol, 2016, 27(12): 3545-3551., articleTitle=null, refAbstract=null), Reference(id=1329869448732849137, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Boels MG, Avramut MC, Koudijs A, et al. Atrasentan reduces albuminuria by restoring the glomerular endothelial glycocalyx barrier in diabetic nephropathy[J]. Diabetes, 2016, 65(8): 2429-2439., articleTitle=null, refAbstract=null), Reference(id=1329869448808346610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Van Aanhold CCL, Dijkstra KL, Bos M, et al. Reduced glomerular endothelial thrombomodulin is associated with glomerular macrophage infiltration in diabetic nephropathy[J]. Am J Pathol, 2021, 191(5): 829-837., articleTitle=null, refAbstract=null), Reference(id=1329869448888038387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Thomas HY, Ford Versypt AN. Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation[J]. J Biol Eng, 2022, 16(1): 19., articleTitle=null, refAbstract=null), Reference(id=1329869448950952948, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Sorokin A, Kohan DE. Physiology and pathology of endothelin-1 in renal mesangium[J]. Am J Physiol Renal Physiol, 2003, 285(4): F579-F589., articleTitle=null, refAbstract=null), Reference(id=1329869449018061813, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Zou HH, Wang L, Zheng XX, et al. Endothelial cells secreted endothelin-1 augments diabetic nephropathy via inducing extracellular matrix accumulation of mesangial cells in ETBR(-/-) mice[J]. Aging (Albany NY), 2019, 11(6): 1804-1820., articleTitle=null, refAbstract=null), Reference(id=1329869449106142198, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Clozel M, Salloukh H. Role of endothelin in fibrosis and anti-fibrotic potential of bosentan[J]. Ann Med, 2005, 37(1): 2-12., articleTitle=null, refAbstract=null), Reference(id=1329869449181639671, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention[J]. J Am Soc Nephrol, 2004, 15(1): 1-12., articleTitle=null, refAbstract=null), Reference(id=1329869449257137144, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Tang L, Li H, Gou R, et al. Endothelin-1 mediated high glucose-induced epithelial-mesenchymal transition in renal tubular cells[J]. Diabetes Res Clin Pract, 2014, 104(1): 176-182., articleTitle=null, refAbstract=null), Reference(id=1329869449349411833, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Franzen S, Palm F. Endothelin type A receptor inhibition normalises intrarenal hypoxia in rats used as a model of type 1 diabetes by improving oxygen delivery[J]. Diabetologia, 2015, 58(10): 2435-2442., articleTitle=null, refAbstract=null), Reference(id=1329869449412326394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Dawood AF, Maarouf A, Alzamil NM, et al. Metformin is associated with the inhibition of renal artery AT1R/ET-1/iNOS axis in a rat model of diabetic nephropathy with suppression of inflammation and oxidative stress and kidney injury[J]. Biomedicines, 2022, 10(7): 1644., articleTitle=null, refAbstract=null), Reference(id=1329869449487823867, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Barton M, Yanagisawa M. Endothelin: 30 years from discovery to therapy[J]. Hypertension, 2019, 74(6): 1232-1265., articleTitle=null, refAbstract=null), Reference(id=1329869449554932732, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou Y, Chi J, Huang Y, et al. Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: a systematic review and meta-analysis of randomized controlled trials[J]. Diabet Med, 2021, 38(1): e14411., articleTitle=null, refAbstract=null), Reference(id=1329869449613652989, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Mann JF, Green D, Jamerson K, et al. Avosentan for overt diabetic nephropathy[J]. J Am Soc Nephrol, 2010, 21(3): 527-535., articleTitle=null, refAbstract=null), Reference(id=1329869449676567550, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Rafnsson A, Bohm F, Settergren M, et al. The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial[J]. Diabetologia, 2012, 55(3): 600-607., articleTitle=null, refAbstract=null), Reference(id=1329869449752065023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Wenzel RR, Littke T, Kuranoff S, et al. Avosentan reduces albumin excretion in diabetics with macroalbuminuria[J]. J Am Soc Nephrol, 2009, 20(3): 655-664., articleTitle=null, refAbstract=null), Reference(id=1329869449819173888, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Kohan DE, Pritchett Y, Molitch M, et al. Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy[J]. J Am Soc Nephrol, 2011, 22(4): 763-772., articleTitle=null, refAbstract=null), Reference(id=1329869449882087424, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Andress DL, Coll B, Pritchett Y, et al. Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)[J]. Life Sci, 2012, 91(13-14): 739-742., articleTitle=null, refAbstract=null), Reference(id=1329869449957584897, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Heerspink HJL, Parving HH, Andress DL, et al. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial[J]. The Lancet, 2019, 393(10184): 1937-1947., articleTitle=null, refAbstract=null), Reference(id=1329869450033082370, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Kohan DE, Lambers Heerspink HJ, Coll B, et al. Predictors of atrasentan-associated fluid retention and change in albuminuria in patients with diabetic nephropathy[J]. Clin J Am Soc Nephrol, 2015, 10(9): 1568-1574., articleTitle=null, refAbstract=null), Reference(id=1329869450100191235, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Schievink B, De Zeeuw D, Smink PA, et al. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers[J]. Eur J Prev Cardiol, 2016, 23(7): 758-768., articleTitle=null, refAbstract=null), Reference(id=1329869450167300100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Koomen JV, Stevens J, Mostafa NM, et al. Determining the optimal dose of atrasentan by evaluating the exposure-response relationships of albuminuria and bodyweight[J]. Diabetes Obes Metab, 2018, 20(8): 2019-2022., articleTitle=null, refAbstract=null), Reference(id=1329869450288934917, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Pena MJ, De Zeeuw D, Andress D, et al. The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy[J]. Diabetes Obes Metab, 2017, 19(5): 749-753., articleTitle=null, refAbstract=null), Reference(id=1329869450477678598, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Heerspink HJ, Makino H, Andress D, et al. Comparison of exposure response relationship of atrasentan between North American and Asian populations[J]. Diabetes Obes Metab, 2017, 19(4): 545-552., articleTitle=null, refAbstract=null), Reference(id=1329869450582536199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Lin CW, Mostafa NM, L Andress D, et al. Relationship between atrasentan concentrations and urinary albumin to creatinine ratio in western and Japanese patients with diabetic nephropathy[J]. Clin Ther, 2018, 40(2): 242-251., articleTitle=null, refAbstract=null), Reference(id=1329869450679005192, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=Heerspink HJL, Xie D, Bakris G, et al. Early response in albuminuria and long-term kidney protection during treatment with an endothelin receptor antagonist: a prespecified analysis from the SONAR trial[J]. J Am Soc Nephrol, 2021, 32(11): 2900-2911., articleTitle=null, refAbstract=null), Reference(id=1329869450758696969, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=Koomen JV, Stevens J, Bakris G, et al. Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: a post hoc analysis of the SONAR trial[J]. Diabetes Obes Metab, 2021, 23(2): 561-568., articleTitle=null, refAbstract=null), Reference(id=1329869450842583050, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=Smeijer JD, Koomen JV, Kohan DE, et al. Organic anion transporter gene variants associated with plasma exposure and long-term response to atrasentan in patients with diabetic kidney disease[J]. Clin Pharmacol Ther, 2022, 112(5): 1098-1107., articleTitle=null, refAbstract=null), Reference(id=1329869450930663435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=Koomen JV, Stevens J, Bakris G, et al. Individual atrasentan exposure is associated with long-term kidney and heart failure outcomes in patients with type 2 diabetes and chronic kidney disease[J]. Clin Pharmacol Ther, 2021, 109(6): 1631-1638., articleTitle=null, refAbstract=null), Reference(id=1329869450993577996, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=Smeijer JD, Koomen J, Kohan DE, et al. Increase in BNP in response to endothelin-receptor antagonist atrasentan is associated with incident heart failure[J]. JACC Heart Fail, 2022, 10(7): 498-507., articleTitle=null, refAbstract=null), Reference(id=1329869451060686861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=Heerspink HJL, Kohan DE, De Zeeuw D. New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction[J]. Kidney Int, 2021, 99(2): 346-349., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329869446300152772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, xref=null, ext=[AuthorCompanyExt(id=1329869446308541381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869446316929990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.01.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.01.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.01.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.01.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1673280000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
内皮素受体拮抗剂治疗糖尿病肾病研究进展
顾思捷 , 范瑛 , 汪年松 *
世界临床药物 | 医药专论 2023,44(1): 8-14
收起
收藏切换
世界临床药物 |医药专论 2023 , 44 (1) : 8 -14
内皮素受体拮抗剂治疗糖尿病肾病研究进展
全屏
[Author(id=1329869446388233160, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869446455342026, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446388233160, language=EN, stringName=Sijie GU, firstName=Sijie, middleName=null, lastName=GU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869446514062283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446388233160, language=CN, stringName=顾思捷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio={"content":"

顾思捷,主治医师,博士研究生在读,研究方向:中西医结合。

"}, bioImg=null, bioContent=

顾思捷,主治医师,博士研究生在读,研究方向:中西医结合。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869446300152772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, xref=null, ext=[AuthorCompanyExt(id=1329869446308541381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869446316929990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])]), Author(id=1329869446581171149, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329869446644085711, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446581171149, language=EN, stringName=Ying FAN, firstName=Ying, middleName=null, lastName=FAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869446711194576, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446581171149, language=CN, stringName=范瑛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869446300152772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, xref=null, ext=[AuthorCompanyExt(id=1329869446308541381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869446316929990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])]), Author(id=1329869446765720530, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329869446845412308, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446765720530, language=EN, stringName=Niansong WANG, firstName=Niansong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329869446904132565, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, authorId=1329869446765720530, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329869446300152772, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, xref=null, ext=[AuthorCompanyExt(id=1329869446308541381, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China), AuthorCompanyExt(id=1329869446316929990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329869445671007169, companyId=1329869446300152772, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学附属上海市第六人民医院肾脏内科,上海 200233)])])]
顾思捷, 范瑛, 汪年松*
作者信息
  • 上海交通大学附属上海市第六人民医院肾脏内科,上海 200233
通讯作者:
汪年松,主任医师,教授,博士研究生导师,研究方向:糖尿病肾脏疾病、急性肾损伤的发病机制和防治。
作者简介:

顾思捷,主治医师,博士研究生在读,研究方向:中西医结合。

Research progress on endothelin receptor antagonist in the treatment of diabetic nephropathy
Sijie GU, Ying FAN, Niansong WANG*
Affiliations
  • Department of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai Sixth People's Hospital, Shanghai 200233, China
出版时间: 2023-01-10 doi: 10.13683/j.wph.2023.01.002
文章导航
收藏切换

糖尿病肾病(diabetic nephropathy,DN)是糖尿病(diabetes mellitus,DM)慢性微血管并发症之一,也是导致终末期肾病(end-stage renal disease,ESRD)的主要原因。我国DM相关慢性肾脏病(chronic kidney disease,CKD)患病率已超过肾小球肾炎(glomerulonephritis,GN)相关CKD,DN已成为危害我国居民健康的一大社会问题。DN治疗方案主要为生活方式改变和药物治疗,但目前临床常用药物仅能减轻症状,延缓疾病进展,需新型药物以改善DN患者总体结局。内皮素受体拮抗剂(endothelin receptor antagonist,ERA)是一类近年被应用于DN治疗的新型药物,效果良好。现对ERA在DN治疗中的临床研究进展作一综述,旨在为临床提供参考。

内皮素受体拮抗剂  /  糖尿病肾病  /  慢性微血管并发症

Diabetic nephropathy (DN) is a chronic microvascular complication of diabetes mellitus (DM), which is also the main cause of end-stage renal disease (ESRD). The prevalence rate of DM related chronic kidney disease (CKD) has exceeded that of glomerulonephritis (GN) related CKD. DN has become a big social problem for Chinese residents. The main treatment options for DN are lifestyle change and drug therapy, but currently common drugs can only reduce symptoms and delay disease progression, and new drugs are needed to improve the overall outcome of DN patients. Endothelin receptor antagonist (ERA), a new class of drugs used in DN in recent years, has shown good effects. This article summarized the clinical research progress of ERA in the treatment of DN, aiming to provide reference for clinical practice.

endothelin receptor antagonist  /  diabetic nephropathy  /  chronic microvascular complication
顾思捷, 范瑛, 汪年松. 内皮素受体拮抗剂治疗糖尿病肾病研究进展. 世界临床药物, 2023 , 44 (1) : 8 -14 . DOI: 10.13683/j.wph.2023.01.002
Sijie GU, Ying FAN, Niansong WANG. Research progress on endothelin receptor antagonist in the treatment of diabetic nephropathy[J]. World Clinical Drug, 2023 , 44 (1) : 8 -14 . DOI: 10.13683/j.wph.2023.01.002

参考文献 引证文献
排序方式:
[1]
Rubanyi GM. The discovery of endothelin: the power of bioassay and the role of serendipity in the discovery of endothelium-derived vasocative substances[J]. Pharmacol Res, 2011, 63(6): 448-454.
[2]
Hickey KA, Rubanyi G, Paul RJ, et al. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells[J]. Am J Physiol, 1985, 248(5 Pt 1): C550-C556.
[3]
Dhaun N, Webb DJ. Endothelins in cardiovascular biology and therapeutics[J]. Nat Rev Cardiol, 2019, 16(8): 491-502.
[4]
Anguiano L, Riera M, Pascual J, et al. Endothelin blockade in diabetic kidney disease[J]. J Clin Med, 2015, 4(6): 1171-1192.
[5]
Yamamoto T, Suzuki H, Kubo Y, et al. Endothelin A receptor-like immunoreactivity on the basal infoldings of rat renal tubules and collecting ducts[J]. Arch Histol Cytol, 2008, 71(2): 77-87.
[6]
Takemoto F, Uchida S, Ogata E, et al. Endothelin-1 and endothelin-3 binding to rat nephrons[J]. Am J Physiol, 1993, 264(5 Pt 2): F827-F832.
[7]
Terada Y, Tomita K, Nonoguchi H, et al. Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay[J]. J Clin Invest, 1992, 90(1): 107-112.
[8]
Bäcker A, Bokemeyer D, Kramer HJ. Endothelin synthesis and receptors in porcine kidney[J]. Acta Physiol Scand, 2001, 171(1): 105-112.
[9]
Guan Z, Vanbeusecum JP, Inscho EW. Endothelin and the renal microcirculation[J]. Semin Nephrol, 2015, 35(2): 145-155.
[10]
Inscho EW, Imig JD, Cook AK, et al. ETA and ETB receptors differentially modulate afferent and efferent arteriolar responses to endothelin[J]. Br J Pharmacol, 2005, 146(7): 1019-1026.
[11]
Schildroth J, Rettig-Zimmermann J, Kalk P, et al. Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice[J]. Nephrol Dial Transplant, 2011, 26(3): 779-789.
[12]
Zhang S, Huang Q, Wang Q, et al. Enhanced renal afferent arteriolar reactive oxygen species and contractility to endothelin-1 are associated with canonical Wnt signaling in diabetic mice[J]. Kidney Blood Press Res, 2018, 43(3): 860-871.
[13]
Barton M, Shaw S, D'uscio LV, et al. Angiotensin Ⅱ increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation[J]. Biochem Biophys Res Commun, 1997, 238(3): 861-865.
[14]
Spires D, Poudel B, Shields CA, et al. Prevention of the progression of renal injury in diabetic rodent models with preexisting renal disease with chronic endothelin A receptor blockade[J]. Am J Physiol Renal Physiol, 2018, 315(4): F977-F985.
[15]
Yamauchi T, Ohnaka K, Takayanagi R, et al. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells[J]. FEBS Lett, 1990, 267(1): 16-18.
[16]
Barton M, Sorokin A. Endothelin and the glomerulus in chronic kidney disease[J]. Semin Nephrol, 2015, 35(2): 156-167.
[17]
Saleh MA, Boesen EI, Pollock JS, et al. Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes[J]. Diabetologia, 2011, 54(4): 979-988.
[18]
Morigi M, Buelli S, Angioletti S, et al. In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies[J]. Am J Pathol, 2005, 166(5): 1309-1320.
[19]
Lenoir O, Milon M, Virsolvy A, et al. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis[J]. J Am Soc Nephrol, 2014, 25(5): 1050-1062.
[20]
Garsen M, Lenoir O, Rops AL, et al. Endothelin-1 induces proteinuria by heparanase-mediated disruption of the glomerular glycocalyx[J]. J Am Soc Nephrol, 2016, 27(12): 3545-3551.
[21]
Boels MG, Avramut MC, Koudijs A, et al. Atrasentan reduces albuminuria by restoring the glomerular endothelial glycocalyx barrier in diabetic nephropathy[J]. Diabetes, 2016, 65(8): 2429-2439.
[22]
Van Aanhold CCL, Dijkstra KL, Bos M, et al. Reduced glomerular endothelial thrombomodulin is associated with glomerular macrophage infiltration in diabetic nephropathy[J]. Am J Pathol, 2021, 191(5): 829-837.
[23]
Thomas HY, Ford Versypt AN. Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation[J]. J Biol Eng, 2022, 16(1): 19.
[24]
Sorokin A, Kohan DE. Physiology and pathology of endothelin-1 in renal mesangium[J]. Am J Physiol Renal Physiol, 2003, 285(4): F579-F589.
[25]
Zou HH, Wang L, Zheng XX, et al. Endothelial cells secreted endothelin-1 augments diabetic nephropathy via inducing extracellular matrix accumulation of mesangial cells in ETBR(-/-) mice[J]. Aging (Albany NY), 2019, 11(6): 1804-1820.
[26]
Clozel M, Salloukh H. Role of endothelin in fibrosis and anti-fibrotic potential of bosentan[J]. Ann Med, 2005, 37(1): 2-12.
[27]
Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention[J]. J Am Soc Nephrol, 2004, 15(1): 1-12.
[28]
Tang L, Li H, Gou R, et al. Endothelin-1 mediated high glucose-induced epithelial-mesenchymal transition in renal tubular cells[J]. Diabetes Res Clin Pract, 2014, 104(1): 176-182.
[29]
Franzen S, Palm F. Endothelin type A receptor inhibition normalises intrarenal hypoxia in rats used as a model of type 1 diabetes by improving oxygen delivery[J]. Diabetologia, 2015, 58(10): 2435-2442.
[30]
Dawood AF, Maarouf A, Alzamil NM, et al. Metformin is associated with the inhibition of renal artery AT1R/ET-1/iNOS axis in a rat model of diabetic nephropathy with suppression of inflammation and oxidative stress and kidney injury[J]. Biomedicines, 2022, 10(7): 1644.
[31]
Barton M, Yanagisawa M. Endothelin: 30 years from discovery to therapy[J]. Hypertension, 2019, 74(6): 1232-1265.
[32]
Zhou Y, Chi J, Huang Y, et al. Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: a systematic review and meta-analysis of randomized controlled trials[J]. Diabet Med, 2021, 38(1): e14411.
[33]
Mann JF, Green D, Jamerson K, et al. Avosentan for overt diabetic nephropathy[J]. J Am Soc Nephrol, 2010, 21(3): 527-535.
[34]
Rafnsson A, Bohm F, Settergren M, et al. The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial[J]. Diabetologia, 2012, 55(3): 600-607.
[35]
Wenzel RR, Littke T, Kuranoff S, et al. Avosentan reduces albumin excretion in diabetics with macroalbuminuria[J]. J Am Soc Nephrol, 2009, 20(3): 655-664.
[36]
Kohan DE, Pritchett Y, Molitch M, et al. Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy[J]. J Am Soc Nephrol, 2011, 22(4): 763-772.
[37]
Andress DL, Coll B, Pritchett Y, et al. Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)[J]. Life Sci, 2012, 91(13-14): 739-742.
[38]
Heerspink HJL, Parving HH, Andress DL, et al. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial[J]. The Lancet, 2019, 393(10184): 1937-1947.
[39]
Kohan DE, Lambers Heerspink HJ, Coll B, et al. Predictors of atrasentan-associated fluid retention and change in albuminuria in patients with diabetic nephropathy[J]. Clin J Am Soc Nephrol, 2015, 10(9): 1568-1574.
[40]
Schievink B, De Zeeuw D, Smink PA, et al. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers[J]. Eur J Prev Cardiol, 2016, 23(7): 758-768.
[41]
Koomen JV, Stevens J, Mostafa NM, et al. Determining the optimal dose of atrasentan by evaluating the exposure-response relationships of albuminuria and bodyweight[J]. Diabetes Obes Metab, 2018, 20(8): 2019-2022.
[42]
Pena MJ, De Zeeuw D, Andress D, et al. The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy[J]. Diabetes Obes Metab, 2017, 19(5): 749-753.
[43]
Heerspink HJ, Makino H, Andress D, et al. Comparison of exposure response relationship of atrasentan between North American and Asian populations[J]. Diabetes Obes Metab, 2017, 19(4): 545-552.
[44]
Lin CW, Mostafa NM, L Andress D, et al. Relationship between atrasentan concentrations and urinary albumin to creatinine ratio in western and Japanese patients with diabetic nephropathy[J]. Clin Ther, 2018, 40(2): 242-251.
[45]
Heerspink HJL, Xie D, Bakris G, et al. Early response in albuminuria and long-term kidney protection during treatment with an endothelin receptor antagonist: a prespecified analysis from the SONAR trial[J]. J Am Soc Nephrol, 2021, 32(11): 2900-2911.
[46]
Koomen JV, Stevens J, Bakris G, et al. Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: a post hoc analysis of the SONAR trial[J]. Diabetes Obes Metab, 2021, 23(2): 561-568.
[47]
Smeijer JD, Koomen JV, Kohan DE, et al. Organic anion transporter gene variants associated with plasma exposure and long-term response to atrasentan in patients with diabetic kidney disease[J]. Clin Pharmacol Ther, 2022, 112(5): 1098-1107.
[48]
Koomen JV, Stevens J, Bakris G, et al. Individual atrasentan exposure is associated with long-term kidney and heart failure outcomes in patients with type 2 diabetes and chronic kidney disease[J]. Clin Pharmacol Ther, 2021, 109(6): 1631-1638.
[49]
Smeijer JD, Koomen J, Kohan DE, et al. Increase in BNP in response to endothelin-receptor antagonist atrasentan is associated with incident heart failure[J]. JACC Heart Fail, 2022, 10(7): 498-507.
[50]
Heerspink HJL, Kohan DE, De Zeeuw D. New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction[J]. Kidney Int, 2021, 99(2): 346-349.
2023年第44卷第1期
10
3
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2023.01.002
  • 接收时间:2022-11-28
  • 首发时间:2026-11-18
  • 出版时间:2023-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-11-28
基金
作者信息
    上海交通大学附属上海市第六人民医院肾脏内科,上海 200233

通讯作者:

汪年松,主任医师,教授,博士研究生导师,研究方向:糖尿病肾脏疾病、急性肾损伤的发病机制和防治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.01.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏